Evidence map›Paper›PMID 35677078›Full record

ArticleResearch square2022

Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.

Philip Schroeder, Laura Brenner, Varinderpal Kaur, Sara Cromer, Katrina Armstrong, Regina LaRocque, Edward Ryan, James Meigs, Jose Florez, Richelle Charles and 2 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Philip SchroederBroad Institute of MIT and Harvard.
Laura BrennerHarvard Medical School.
Varinderpal KaurMassachusetts General Hospital.
Sara CromerHarvard Medical School.
Katrina ArmstrongHarvard Medical School.
Regina LaRocqueHarvard Medical School.
Edward RyanHarvard Medical School.
James MeigsHarvard Medical School.
Jose FlorezHarvard Medical School.
Richelle CharlesHarvard Medical School.
Josep MercaderBroad Institute of MIT and Harvard.
Aaron LeongHarvard Medical School.
Harvard University · USBroad Institute · USMassachusetts General Hospital · US

Funding

TRAINING PROGRAM IN ENDOCRINOLOGY AND DIABETEST32DK007028 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Karen K Miller · 1986 to 2026
$18.5M
TOPMed Omics of Type 2 Diabetes and Quantitative TraitsUM1DK078616 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MANNING, ALISA KNODLE · 2021 to 2025
$3.8M
TOPMed Omics of Cardiovascular Disease in DiabetesR01HL151855 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MEIGS, JAMES B · 2020 to 2023
$3.3M
Genetics, glycemic control and the microbiome in cystic fibrosisK23DK125839 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BRENNER, LAURA N · 2020 to 2024
$1.1M
The Effect of Socioeconomic Status on Outcomes in Type 2 Diabetes Clinical TrialsF32DK127545 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI CROMER, SARA JANE · 2020 to 2020
$76k
ACL HHS U01CK000490NCEZID CDC HHS U01 CK000490NCEZID CDC HHS U01 CK000633NHLBI NIH HHS R01 HL151855NIDDK NIH HHS F32 DK127545NIDDK NIH HHS K23 DK125839NIDDK NIH HHS T32 DK007028NIDDK NIH HHS UM1 DK078616
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35677078
PMCPMC9176658
OpenAlexW4281962394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.